DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Indibulin is an investigational drug.
There have been 6 clinical trials for Indibulin. The most recent clinical trial was a Phase 1 trial, which was initiated on March 1st 2010.
The most common disease conditions in clinical trials are Breast Neoplasms and [disabled in preview]. The leading clinical trial sponsors are Ziopharm, Memorial Sloan Kettering Cancer Center, and [disabled in preview].
Recent Clinical Trials for Indibulin
|Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer||Memorial Sloan Kettering Cancer Center||Phase 1/Phase 2|
|Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer||Ziopharm||Phase 1/Phase 2|
|Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors||Ziopharm||Phase 1/Phase 2|